Global Regulatory

News
August 21, 2017

There is a hope on the very horizon for people suffering from low back pain. A relatively new procedure known as minimally invasive nerve-ablating procedure seems to be effective in treating some forms of back pain and may offer a new treatment option.

FDA
7min read    
News
August 21, 2017

FDA approves ixekizumab for psoriasis. There is a hope that will compete against a new wave of rival therapies for psoriasis. 

FDA
4min read    
News
August 21, 2017

Cardiovascular risks possess a great threat when one takes up the arthritis drugs. Thus, the researchers may be on their way to finding safer drugs for arthritis treatment that don't lead to potentially harmful cardiovascular side effects.

European Medicines Agency
5min read    
News
August 19, 2017

According a report was published online in the journal Arthritis & Rheumatology, an advanced blood test predict treatment response in patients suffering from rheumatoid arthritis (RA). 

Globe NewsWire
9min read    
News
August 19, 2017

Two spine-related studies have been recognised as the research highlights for 2016 by US National Institutes of Health (NIH). Research into the effects of meditation and cognitive behavioural therapy on low back pain has been regarded as “Clinical Breakthrough”, while a study investigating the ability of electrical epidural stimulation to help move the hands of paralysed individuals was regarded as“Promising Medical Advance”.

NIH
14min read